IL17A and rheumatoid arthritis: Since the initial phase of RA involves an imbalance of proinflammatory and anti-inflammatory cytokine activities, increasing proinflammatory cytokines such as TNF-α, IL-6, and IL-17 could stimulate inflammation and degradation of bone and cartilage [43].